scholarly journals Determinants of Non-Disclosure to Sexual Partner among Human immune virus Infected Adults on Anti-Retroviral Therapy Follow-Up Care at North Shewa Zone public Hospitals in Oromia Region, Ethiopia, 2020.

Author(s):  
Tiliksew Liknaw Alemineh ◽  
Mengistu Benayew Shifraew ◽  
Muluken Ayenew Shibabaw ◽  
Andualem Gezahegn Kebede ◽  
Mihretie Gedfew Birlie ◽  
...  

Abstract BackgroundHIV positive status non-disclosure to sexual partner remains challenging for the prevention and control of Human Immune Virus infection as it results in poor antiretroviral treatment adherence, high risk of transmission and limits women’s ability in the prevention of mother to child transmission. ObjectiveThe study tried to identify determinants of non-disclosure to sexual partner/s among Human immune virus infected Adult on Anti-Retroviral Therapy Follow-Up Care at North Shewa zone public Hospitals in Oromia Region, Ethiopia, 2020. MethodsA hospital based unmake case control study was conducted from December 1 to February 30/2020 among 378 (94 cases and 284 controls) Human immune virus infected adults on Anti-Retroviral Therapy Follow-Up Care at North Shewa zone public Hospitals in Oromia Region, Ethiopia, 2020. Epi data version 3.1 for data entry and SPSS version 25 for analysis were used. To find factors significantly associated with non-disclosure to sexual partner/s, Bivariable and Multivariable logistic regression analysis were done. ResultOf a total of 378 sampled study respondents, 369 were interviewed (92 cases and 277 controls) giving response rate of 97.5%. Among the study participants 39.3% (36 cases and 109 controls) were in the age group of 31-40 years and more than half of the respondents, 53.4% (61 cases and 136 controls) were females. Regarding educational and marital status, 39.3% (100 controls and 45 cases) were unable to read and write and 69.6% (211 controls and 46 cases) were married. Variables that showed significant association with non-disclosure to sexual partner were male sex (AOR: 0.25, 95% CI: 0.13-0.47), ART duration <36 months (AOR:2.13, 95% CI: 1.14-4.01), Being on WHO clinical staging one (AOR: 3.00, 95% CI: 1.26-7.12), Having more than one lifetime sexual partner (AOR: 0.46, 95% CI: 0.22-0.95) and not seeing person/s publically disclosed HIV status (AOR: 3.12, 95% CI: 1.47-6.65). ConclusionsThis study endorsed that promoting public HIV disclosure and having one sexual partner helps disclosure to sexual partner/s. Deep and continuous HIV disclosure counseling service is needed for Female, for those being in WHO clinical staging one and ART duration <36 months.

2017 ◽  
Vol 41 (4) ◽  
pp. 401 ◽  
Author(s):  
Marina Kunin ◽  
Erin Turbitt ◽  
Sarah A. Gafforini ◽  
Lena A. Sanci ◽  
Neil A. Spike ◽  
...  

Objective The aim of the present study was to examine factors associated with: (1) parental preference to receive follow-up care for their child from a general practitioner (GP); and (2) a decision to seek treatment when there is a slight worsening of their child’s condition. Methods Parents presenting with their child at any one of five paediatric out-patient clinics at two public hospitals in Melbourne (Vic., Australia) were surveyed. We performed frequency distributions, bivariate analyses and multivariate logistic regression to evaluate associations with the preference for a GP for follow-up care and treatment in case of a slight worsening. Results In all, 606 parents were recruited to the study, 283 being new presentations and 323 presenting for review. GPs were selected as the preference for follow-up care by 23% (n = 142) of respondents, and 26% (n = 160) reported they would seek treatment from a GP if the condition of their child were to worsen slightly. There was an increased likelihood to prefer a GP for follow-up care for new patients (odds ratio (OR) 3.10; 95% confidence interval (CI) 1.99–4.83), those attending general paediatrics clinic (OR 1.73; 95% CI 1.11–2.70), and parents with a lower level of education (OR 1.74; 95% CI 1.09–2.78). For review patients, if during the previous visit a paediatrician suggested follow-up with a GP, parents were more likely to prefer a GP as a follow-up provider (OR 6.70; 95% CI 3.42–13.10) and to seek treatment from a GP in case of a slight worsening (OR 1.86; 95% CI 1.03–3.37). Conclusion Most parents attending paediatric out-patient appointments prefer to return for follow-up care; however, a paediatrician’s advice may have an important role in return of paediatric patients to primary care. What is known about the topic? In Australia, there has been a growing concern regarding long waiting times for specialist consultations in out-patient clinics and difficulties with access for new patients. This has occurred when the ratio of review attendees to new patients has tipped towards the review attendees. What does this paper add? Most parents of children attending paediatric out-patient clinics value follow-up care with paediatric specialists, even if the referring GP requested a return to their surgery. The advice of the consulting paediatrician in support of follow-up care with a GP contributes significantly to the willingness of parents to return to primary care and to seek treatment from their GP for a slight worsening of their child’s condition. What are the implications for practitioners? The findings of the present study have significant implications for the discharge of patients from speciality care: paediatricians can have an important role in the return of paediatric patients to primary care.


2007 ◽  
Vol 41 (1) ◽  
pp. 23
Author(s):  
BRUCE K. DIXON
Keyword(s):  

Author(s):  
S Wojcinski ◽  
A Farrokh ◽  
U Hille ◽  
E Hirschauer ◽  
W Schmidt ◽  
...  

1998 ◽  
Author(s):  
Sherrie H. Kaplan ◽  
Rebecca A. Silliman

2020 ◽  
Vol 16 (32) ◽  
pp. 2635-2643
Author(s):  
Samantha L Freije ◽  
Jordan A Holmes ◽  
Saleh Rachidi ◽  
Susannah G Ellsworth ◽  
Richard C Zellars ◽  
...  

Aim: To identify demographic predictors of patients who miss oncology follow-up, considering that missed follow-up has not been well studies in cancer patients. Methods: Patients with solid tumors diagnosed from 2007 to 2016 were analyzed (n = 16,080). Univariate and multivariable logistic regression models were constructed to examine predictors of missed follow-up. Results: Our study revealed that 21.2% of patients missed ≥1 follow-up appointment. African–American race (odds ratio [OR] 1.33; 95% CI: 1.17–1.51), Medicaid insurance (OR 1.59; 1.36–1.87), no insurance (OR 1.66; 1.32–2.10) and rural residence (OR 1.78; 1.49–2.13) were associated with missed follow-up. Conclusion: Many cancer patients miss follow-up, and inadequate follow-up may influence cancer outcomes. Further research is needed on how to address disparities in follow-up care in high-risk patients.


Sign in / Sign up

Export Citation Format

Share Document